A phase Ia clinical trial of Non-Hodgkin's-lymphoma-vaccine

Trial Profile

A phase Ia clinical trial of Non-Hodgkin's-lymphoma-vaccine

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Apr 2017

At a glance

  • Drugs Non Hodgkin's lymphoma vaccine XEME Biopharma (Primary) ; Antineoplastics
  • Indications Follicular lymphoma; Non-Hodgkin's lymphoma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 21 Apr 2017 Results published in the XEME Biopharma Inc company website. (http://www.xemebiopharma.com/experimental-and-clinical-evidence).
    • 21 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top